These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 37201251)

  • 21. Tumour characteristics provide evidence for germline mismatch repair missense variant pathogenicity.
    Li S; Qian D; Thompson BA; Gutierrez S; Wu S; Pesaran T; LaDuca H; Lu HM; Chao EC; Black MH
    J Med Genet; 2020 Jan; 57(1):62-69. PubMed ID: 31391288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel gene-specific Bayesian Gaussian mixture model to predict the missense variants pathogenicity of Sanfilippo syndrome.
    Mohammed EEA; Fayez AG; Abdelfattah NM; Fateen E
    Sci Rep; 2024 May; 14(1):12148. PubMed ID: 38802532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodal framework to resolve variants of uncertain significance in
    Biar CG; Pfeifer C; Carvill GL; Calhoun JD
    bioRxiv; 2024 Jun; ():. PubMed ID: 38895336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic prediction of familial hypercholesterolemia caused by low-density lipoprotein receptor missense mutations.
    Guo J; Gao Y; Li X; He Y; Zheng X; Bi J; Hou L; Sa Y; Zhang M; Yin H; Jiang L
    Atherosclerosis; 2019 Feb; 281():1-8. PubMed ID: 30583242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis and Interpretation of the Impact of Missense Variants in Cancer.
    Petrosino M; Novak L; Pasquo A; Chiaraluce R; Turina P; Capriotti E; Consalvi V
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of BRCA1 ring finger variants of uncertain significance.
    Sweet K; Senter L; Pilarski R; Wei L; Toland AE
    Breast Cancer Res Treat; 2010 Feb; 119(3):737-43. PubMed ID: 19543972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53_PROF: a machine learning model to predict impact of missense mutations in TP53.
    Ben-Cohen G; Doffe F; Devir M; Leroy B; Soussi T; Rosenberg S
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35043155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CoDP: predicting the impact of unclassified genetic variants in MSH6 by the combination of different properties of the protein.
    Terui H; Akagi K; Kawame H; Yura K
    J Biomed Sci; 2013 Apr; 20(1):25. PubMed ID: 23621914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using AI-predicted protein structures as a reference to predict loss-of-function activity in tumor suppressor breast cancer genes.
    Gnanaolivu R; Hart SN
    Comput Struct Biotechnol J; 2024 Dec; 23():3472-3480. PubMed ID: 39430403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of all
    Kimura H; Lahouel K; Tomasetti C; Roberts NJ
    bioRxiv; 2024 Sep; ():. PubMed ID: 38234851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improving the clinical interpretation of missense variants in X linked genes using structural analysis.
    Sallah SR; Ellingford JM; Sergouniotis PI; Ramsden SC; Lench N; Lovell SC; Black GC
    J Med Genet; 2022 Apr; 59(4):385-392. PubMed ID: 33766936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional Evaluation of Nine Missense-Type Variants of the Human DNA Glycosylase Enzyme MUTYH in the Japanese Population.
    Shinmura K; Kato H; Goto M; Yamada H; Tao H; Nakamura S; Sugimura H
    Hum Mutat; 2016 Apr; 37(4):350-3. PubMed ID: 26694661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of functional variants and protein-to-protein physical interactions of human MutY homolog linked with familial adenomatous polyposis and colorectal cancer syndrome.
    Abduljaleel Z; Athar M; Al-Allaf FA; Al-Dehlawi S; Vazquez JR
    Noncoding RNA Res; 2019 Dec; 4(4):155-173. PubMed ID: 32072083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DVA: predicting the functional impact of single nucleotide missense variants.
    Wang D; Li J; Wang E; Wang Y
    BMC Bioinformatics; 2024 Mar; 25(Suppl 1):100. PubMed ID: 38448823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML.
    Hart SN; Polley EC; Shimelis H; Yadav S; Couch FJ
    NPJ Breast Cancer; 2020; 6():13. PubMed ID: 32377563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predicting deleterious missense genetic variants via integrative supervised nonnegative matrix tri-factorization.
    Arani AA; Sehhati M; Tabatabaiefar MA
    Sci Rep; 2021 Dec; 11(1):23747. PubMed ID: 34887492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity.
    Guidugli L; Pankratz VS; Singh N; Thompson J; Erding CA; Engel C; Schmutzler R; Domchek S; Nathanson K; Radice P; Singer C; Tonin PN; Lindor NM; Goldgar DE; Couch FJ
    Cancer Res; 2013 Jan; 73(1):265-75. PubMed ID: 23108138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LYRUS: a machine learning model for predicting the pathogenicity of missense variants.
    Lai J; Yang J; Gamsiz Uzun ED; Rubenstein BM; Sarkar IN
    Bioinform Adv; 2022; 2(1):vbab045. PubMed ID: 35036922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants.
    Fortuno C; James PA; Young EL; Feng B; Olivier M; Pesaran T; Tavtigian SV; Spurdle AB
    Hum Mutat; 2018 Aug; 39(8):1061-1069. PubMed ID: 29775997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.